Abstract
The pivotal role of ammonia in the pathogenesis of HE in acute liver failure is incontrovertible, but in chronic liver disease a consistent correlation between the concentration of ammonia in the blood and the manifest symptoms of HE is not always observed. Over the past decade, we have begun to characterise the important roles of inflammation, infection, and oxidative stress in modulating the pathophysiological effects of ammonia on the astrocyte, the most commonly affected cell neuropathologically. The synergistic role of inflammation and infection in modulating the cerebral effects of ammonia has been demonstrated and a degree of overlap with sepsis-associated encephalopathy has been postulated. Ammonia may “sensitise” the brain to a systemic inflammatory stimulus which results in a response involving proinflammatory and neurotransmitter pathways. Brain microglial activation may also be implicated. Ammonia has also been shown to induce immune dysfunction with the release of reactive oxygen species from neutrophils which contribute to oxidative stress and systemic inflammation. Not only can this exacerbate the cerebral effects of ammonia but it may also make the individual vulnerable to developing infection which will further predispose to the manifestation of covert or overt HE. This chapter explores the current thoughts and evidence base on this area and discusses the role of existing and novel therapies that might be utilised in those predisposed to developing HE.
The authors Shabnam S. Shabbir and Amit Singh Seyan contributed equally to this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nencki M, Pawlow J, Zaleski J. Ueber den ammoniakgehalt des blutes under der organe und die harnstoffbildung bei den saugethieren. Arch Exp Pathol Pharmakol. 1896;37:26–51.
Clemmesen J, Larsen F, Kondrup J, Hansen B, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology. 1999;29:648–53.
Bernal W, Hall C, Karvellas C, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46(6):1844–52.
Ong JP, Aggarwal A, Krieger D, Easley KA, Karafa MT, Van Lente F, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003; 114(3): 188–93.
Shawcross D, Sharifi Y, Canavan J, Yeoman A, Abeles R, Taylor N, et al. Infection and systemic inflammation, not ammonia, are associated with grade III/IV hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol. 2011;54(4):640–9.
Arora S, Martin CL, Herbert M. Myth: interpretation of a single ammonia level in patients with chronic liver disease can confirm or rule out hepatic encephalopathy. CJEM. 2006;8(6):433–5.
Zieve FJ, Zieve L, Doizaki WM, Gilsdorf RB. Synergism between ammonia and fatty acids in the production of coma: implications for hepatic coma. J Pharmacol Exp Ther. 1974;191(1):10–6.
Wasmuth H, Kunz D, Yagmur E, Timmer-Stranghoner A, Vidacek D, Siewart E, et al. Patients with acute on chronic liver failure display ‘sepsis-like’ immune paralysis. J Hepatol. 2005;42:195–201.
Antoniades C, Berry P, Wendon J, Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol. 2008;49:845–61.
Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson A, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 1990;11(1):49–53.
Jalan R, Pollok A, Shah SH, Madhavan K, Simpson KJ. Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in acute liver failure. J Hepatol. 2002;37(4):536–8.
Wright G, Shawcross D, Olde Damink S, Jalan R. Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension. Metab Brain Dis. 2007;22(3–4):375–88.
Rajkovic IA, Williams R. Mechanisms of abnormalities in host defences against bacterial infection in liver disease. Clin Sci (Lond). 1985;68(3):247–53.
Rajkovic IA, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology. 1986;6(2):252–62.
Mookerjee R, Stadlbauer V, Lidder S, Wright G, Hodges S, Davies N, et al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts outcome. Hepatology. 2007;46(3):831–40.
Bode C, Kugler V, Bode J. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol. 1987;4:8–14.
Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med. 1996;125(8):680–7.
Papadopoulos MC, Davies DC, Moss RF, Tighe D, Bennett ED. Pathophysiology of septic encephalopathy: a review. Crit Care Med. 2000;28(8):3019–24.
Licinio J, Wong M. Pathways and mechanisms for cytokine signalling of the central nervous system. J Clin Invest. 1997;100:2941–7.
Didier N, Romero IA, Creminon C, Wijkhuisen A, Grassi J, Mabondzo A. Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability. J Neurochem. 2003;86(1):246–54.
Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000;32:734–9.
Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003;125(3): 755–64.
Jalan R, Olde Damink S, Deutz N, Lee A, Hayes P. Treatment of uncontrolled intracranial hypertension in acute liver failure with moderate hypothermia. Lancet. 1999;354:1164–8.
Jalan R, Olde Damink SW, Hayes PC, Deutz NE, Lee A. Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol. 2004;41(4):613–20.
Shawcross D, Wright G, Olde Damink S, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis. 2007;22:125–38.
Shawcross D, Davies N, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol. 2004;40(2):247–54.
Marini JC, Broussard SR. Hyperammonemia increases sensitivity to LPS. Mol Genet Metab. 2006;88(2):131–7.
Jover R, Rodrigo R, Felipo V, Insausti R, Saez-Valero J, Garcia-Ayllon MS, et al. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: a model of hepatic encephalopathy in cirrhosis. Hepatology. 2006;43(6):1257–66.
Wright G, Davies N, Shawcross D, Hodges S, Zwingmann C, Brooks H, et al. Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology. 2007;45(6):1517–26.
Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V. Inflammation and hepatic encephalopathy: ibuprofen restires learning ability in rats with portacaval shunts. Hepatology. 2007;46:514–9.
Clemmesen JO, Hansen BA, Larsen FS. Indomethacin normalizes intracranial pressure in acute liver failure: a twenty-three-year-old woman treated with indomethacin. Hepatology. 1997;26(6):1423–5.
Tofteng F, Larsen FS. The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab. 2004;24(7):798–804.
Chung C, Gottstein J, Blei AT. Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis. Hepatology. 2001;34(2):249–54.
Shawcross DL, Shabbir SS, Taylor NJ, Hughes RD. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology. 2010;51(3):1062–9.
Shawcross D, Wright G, Stadlbauer V, Hodges S, Wheeler-Jones C, Pitsillides A, et al. Ammonia impairs neutrophil phagocytic function in liver disease. Hepatology. 2008;48(4):1202–12.
Haussinger D, Graf D, Weiergraber O. Glutamine and cell signaling in the liver. J Nutr. 2001;131:2509S–14.
Jayakumar A, Panickar K, Murthy C, Norenberg M. Oxidative stress and mitogen-activated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J Neurosci. 2006;26(18):4774–84.
Stadlbauer V, Mookerjee R, Wright G, Davies N, Jurgens G, Hallstrom S, et al. Role of toll-like receptors 2, 4 and 9 in mediating neutrophils dyfunction in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol. 2009;296(1):G15–22.
Lu W, Maheshwari A, Misiuta I, Fox S, Chen N, Zigova T, et al. Neutrophil-specific chemokines are produced by astrocytic cells but not neuronal cells. Dev Brain Res. 2005;155:127–34.
Bernal W, Auzinger G, Sizer E, Wendon J. Intensive care management for acute liver failure. Semin Liver Dis. 2008;28(2):188–200.
Als-Nielsen B, Gluud L, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. Br Med J. 2004;328:1046–50.
Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071–81.
Bajaj JS, Heuman DM, Wade JB, Gibson DP, Saeian K, Wegelin JA, et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology. 2011;140(2):478–87.
Rolando N, Clapperton M, Wade J, Panetsos G, Mufti G, Williams R. Granulocyte colony-stimulating factor improves function of neutrophils from patients with acute liver failure. Eur J Gastroenterol Hepatol. 2000;12(10):1135–40.
Treacher D, Sabbato M, Brown K, Gant V. The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass. Perfusion. 2001;16:67–73.
Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med. 1991;324(26):1852–7.
Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39(5):1441–9.
Shawcross D, Davies N, Hodges S, Wright G, Jalan R. Hypothermia abolishes ammonia-induced neutrophil spontaneous oxidative burst [abstract]. Hepatology. 2006;44(4 Suppl 1):363A.
Jalan R, Schnurr K, Mookerjee R, Sen S, Cheshire L, Hodges S, et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology. 2009;50(2):555–64.
Jiang W, Desjardins P, Butterworth R. Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline. J Neurochem. 2009;109(2):485–93.
Stadlbauer V, Mookerjee R, Hodges S, Wright G, Davies N, Jalan R. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol. 2008;48(6):945–51.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Shabbir, S.S., Seyan, A.S., Shawcross, D.L. (2012). Inflammation and Hepatic Encephalopathy. In: Mullen, K., Prakash, R. (eds) Hepatic Encephalopathy. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-836-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-61779-836-8_4
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-835-1
Online ISBN: 978-1-61779-836-8
eBook Packages: MedicineMedicine (R0)